Palio - Never Be Forgotten

Never Be Forgotten

You are here: Home / Archives for oncology

Common Imagery in Cancer Related Advertising

August 4, 2010 By jfisher Leave a Comment

From Alan Steele VP, Director of Studio Services, Palio

First and foremost, people view cancer as a life-threatening disease. On top of it, cancer treatments are seen as lengthy, invasive, and debilitating courses of action. And for most people, cancer is a malady only to be discussed with their doctor and closest friends and family.

Advertising agencies that create communications for oncology or cancer prevention therapies and fund-raising organizations have identified these concerns and usually rely on three specific imagistic themes when appealing to cancer caregivers and patients, which I list as: 1) survivors, 2) lifestyles, and 3) loved ones. By using images that depict survivors, images that show freedom of movement in active lifestyles, and images that reinforce the importance of continued connections with loved ones, the unbranded or branded communications give cancer patients a picture to ‘aspire’ to.  As one doctor wrote, “If you really wanted to give people real information, you would give them statistics, but that wouldn’t be nearly as compelling.” So, touching emotions is the main driver in all of these categories.

Survivor Imagery


Breakthrough Breast Cancer is the leading UK charity committed to fighting breast cancer. The black and white photograph with a polaroid-like white border stuck to a pink memo board with a push pin is almost documentary in style. The woman wears a white terry robe (healing after battle). She is at home alone in the kitchen pondering what she has been through. The Erbitux ad, cetuximab injection for head and neck cancer, pictures a rugged, bearded, outdoor-type of man holding a black and white x-ray of his skull and neck vertebrae.

Lifestyle imagery

The DTC TV commercial for Gardasil, a human papillomavirus (HPV) vaccine from Merck that helps protect against 4 types of HPV, shows images of girls playing soccer, skateboarding, jumping rope, and playing drums. There are about 6 million new cases of genital HPV cases annually, 74% in the 15 to 24 year old age range.

Gemzar is a Lilly product that treats recurring ovarian cancer. This professional ad balances the lifestyle story with clinical data. A close-up photograph of a woman with snow goggles that reflect the arctic landscape, the massive fur head covering, and the film clips of mushing huskies all symbolize her challenging life journey with recurring cancer.

Loved ones imagery

The GlaxoSmithKline DTC TV commercial for cervical cancer shows a young woman on the front porch of a friends’ country home in winter. She has gone outside to make a private cell phone call to another friend so her friend inside won’t hear what she is saying. “Where are you?” “I’m with Kate, she has cervical cancer.” “What did you say?” “What could I say?”

The American Cancer Society’s More Birthdays TV campaign shows surprise birthday parties among friends, couples in a restaurant being given a birthday cake by the waiter, and scenes at home of couples of all ages with birthday cake and candles.

A television commercial by Australian Suncorp shows images of a mother and baby in a nursery, a crossing guard helping schoolchildren cross the street, and families at home preparing to go out in the sun. “It’s our way of life to protect ourselves and those we love.” The message is that others initially take care of us, then as we age, we must take care of ourselves and others.

The UK print ad by The Roy Castle Lung Cancer Foundation pictures a little girl with her doll seated in a grown-up leather chair. Her right arm is that of her mother, large and flabby with jewelry, nail polish, and a burning cigarette. The ad addresses the problem of second-hand smoke in the home.

The examples go on. These are typical images seen in messages about cancer or cancer-related products. Maybe there’s room to go about things differently? What do you think?

Palio is a full-spectrum global pharmaceutical and consumer advertising, marketing, and communications agency that excels in brand creation and specializes in brand strategy, product launches, global marketing, and digital and integrated media.

Tweet
Filed Under: Creative, Oncology Tagged With: campaign imagery, cancer, oncology

Tweetings from ASCO 2010

June 7, 2010 By jfisher 1 Comment

From Maureen Wendell, VP, Account Services, Palio

In 2009, I attended several diabetes medical meetings (ADA, AACE, ENDO, AADE) and noted a modest digital footprint – wireless café and abstracts on CD. Ho hum. At ASCO 2010, I was amazed at the transformation. Is it the progressive oncology community or a sign of the rapidly changing world of digital communications and social media? The answer is yes.

Oncology by its very nature is one of the more technologically savvy disciplines and its specialists are highly interested in engaging online according to Manhattan Research (2009 ePharma Physician v9.0 #6). Disease complexity, extensive tumor classifications, rapidly evolving diagnostics, genomics and treatments have created a community thirsty for information and communication. And ASCO has stepped up to satisfy its members’ appetite.

From their networking website – ascoexchange.org – to the ASCO 2010 “Tweetup” held in Chicago on Saturday to gather physician insights on unmet needs and new opportunities – ASCO is clearly telling us that online communities and social media matters. Here are a few examples:

Twitter – over 2,000 followers are kept up to date on trial results, award winners, podcasts, schedule changes and membership benefits.

Dr. Blayney’s Blog – ASCO’s President is leading the way with his own blog where he shares experiences on EHR, e-prescribing, and safety standards.

Oncology EHR Exchange – in this ASCO forum, 450 members, including EHR vendors, can discuss electronic health records. Dr. Blayney was recently quoted in ASCO News stating: “It would be great to see online conversations start up around each of the major EHR vendors, so that those who are interested in purchasing or acquiring this technology can learn from our experiences with EHR products. Vendor representatives participate in the Oncology EHR Exchange and check in to see what users are saying. Unlike a yearly meeting, we can use this forum to create a virtual users’ group with the opportunity for continuous learning.”

Here we have ASCO leadership asking an industry stakeholder for help in satisfying the need for continuous learning. While many pharma brands focus on patient communities as they navigate the brave new world, are they missing an opportunity to take a leadership role in meeting this important need for healthcare professionals?

Palio is a full-spectrum global pharmaceutical and consumer advertising, marketing, and communications agency that excels in brand creation and specializes in brand strategy, product launches, global marketing, and digital and integrated media.
Tweet
Filed Under: Account Services Tagged With: ASCO, diabetes, digital, Manhattan Research, oncology, social media

What’s In a Name?

April 22, 2010 By jfisher 1 Comment

From Ian DeMeritt, Senior Medical Writer, Palio

“What’s in a name? That which we call a rose by any other name would smell as sweet.” – Romeo and Juliet (Act II, scene II)

What if that rose didn’t have a name, yet claimed that it smelled sweet?

Late last week, DDMAC issued several regulatory letters to pharmaceutical companies, bringing the total number of letters it has issued so far in 2010 to 22, already topping the 21 letters sent in 2008. Of interest was a letter addressed to GlaxoSmithKline for an unbranded, single-page ad (also shown above) placed in the Journal of Clinical Oncology last December.

The simple ad announced that a “New Treatment Option for Refractory Chronic Lymphocytic Leukemia (CLL)” was “NOW APPROVED.” A footnote clarified the treatment was for CLL “refractory to fludarabine and alemtuzumab,” and a disease-specific Web-site address (www.cllinformation.com) and the GSK logo were included on the bottom of the page. That’s it. No efficacy data were included, no overt promotional claims were made, and no fancy images of happy people walking along a beach were present.

Most importantly, however, no safety information was contained in the ad, despite its unbranded nature.

Even though the name of the treatment was not provided, DDMAC considered the ad misleading because “the characteristics of the product promoted in the ad can only describe Arzerra,“ the only drug recently approved by the FDA to treat refractory CLL. Because the promotional material could only apply to a single product, the ad was effectively considered a branded advertisement requiring full disclosure of safety and risk information.

In our line of work, the response to what we perceive as unfair feedback from a client’s regulatory team is often jokingly along the lines of “can’t we just turn this into an unbranded campaign?” thinking that by simply removing the branding elements, the regulatory requirements will also magically disappear.

However, one of the important lessons to be learned from this letter is that a pharmaceutical brand comprises more than just a logo and color pallete. The totality of the message being conveyed must also be considered a key branding element, especially in the eyes of the FDA.

This latest DDMAC letter provides a useful reminder that failing to call a rose by its name doesn’t make it any less of a rose.

Palio is a full-spectrum global pharmaceutical and consumer advertising, marketing, and communications agency that excels in brand creation and specializes in brand strategy, product launches, global marketing, and digital and integrated media.
Tweet
Filed Under: Industry Trends, Medical Strategy Tagged With: DDMAC, FDA, oncology, regulatory, warning letter
Subscribe

Palio on Twitter

  • #SuperBowl #advertising will engage more than ever http://t.co/qcL4HBYO 04:31:58 PM February 03, 2012 from HootSuite ReplyRetweetFavorite
  • Searching for side effects: http://t.co/cTpPhKHa #pharmaceuticalmarketing 02:37:23 PM February 03, 2012 from TweetDeck ReplyRetweetFavorite
  • Pharma & Facebook timeline cld showcase product innovation http://t.co/Xa5uY95w w/ http://t.co/mZJke2RO #facebook #socpharm #hcsm 06:48:30 PM January 31, 2012 from HootSuite ReplyRetweetFavorite
  • #Twitter Upgrades Will Include Analytical Tools http://t.co/IGrr7Wov 07:50:24 PM January 30, 2012 from HootSuite ReplyRetweetFavorite
  • How USA Today's Ad Meter Broke #SuperBowl #Advertising | Digital - Advertising Age http://t.co/ZxzHolkA 01:50:19 PM January 30, 2012 from HootSuite ReplyRetweetFavorite
@paliosaratoga

Tags

Advertising Advertising Age app Apple apps blog branding Brand Planning business cancer clients Coca Cola collaboration Communication Creative creativity DDMAC design diabetes digital digital contexts editing Editorial Facebook FDA Google Haiti HIV ideas iPad marketing Mike Myers NEJM oncology Palio personality Pharma positioning QR codes research social media Todd LaRoche Twitter warning letter YouTube

Categories

  • Account Services
  • Advertising
  • Brand Planning
  • Career
  • Creative
  • Editorial
  • Family
  • Industry Trends
  • Lifestyles
  • Media
  • Medical Strategy
  • Oncology
  • Research
  • Social Media
  • Technology
  • Uncategorized

Blogroll

  • 4As Business Development Blog
  • Ad Forum
  • Ad Freak
  • Ad Lab
  • Ad Land
  • Ad Mad
  • Ad Pulp
  • Ad Rants
  • AdPharmBlog
  • Advertising Age
  • Behind Online Pharma
  • Beyond Madison Avenue
  • Brand Salsa
  • Business Week Pharmaceutical Industry Blog
  • Cafe Pharma
  • Community Pharm
  • Consumer Reports Health Blog
  • Creativity Portal
  • Digital Marketing Grab Bag
  • Documentation
  • Dose of Digital
  • e-Patients.net
  • Eye for Pharma
  • Eye on FDA
  • FiercePharma
  • From Bogota With Love
  • Fuel Lines
  • Furious Seasons
  • HealthCareVox
  • IdeaPharmer
  • Internet Drug News
  • Jim Edwards’ NRx
  • Make The Logo Bigger
  • Marketing Vox
  • MedAdNews
  • Pharm-Land
  • Pharma Blog Review
  • Pharma Exec Blog
  • Pharma Marketing Blog
  • Pharmagossip
  • Pharmalot
  • PharmExec
  • Phil Baumann
  • Pixels & Pills
  • The Ad Guy
  • The Big Red Biotech Blog
  • TWTRCON
  • Wall Street Journal Health Blog
  • World of DTC Marketing

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Return to top of page

Copyright © 2012 Palio · WordPress · Log in